Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1998-5-21
|
pubmed:abstractText |
Effect of oxyfedrine (OXF)(1 mg/kg) administered just before reperfusion (post-treatment) was investigated in a canine model of myocardial stunning. In the saline-treated animals, myocardial stunning was evidenced by fall in MAP, decrease in LV peak (+) dP/dt, rise in LVEDP and incomplete regeneration of myocardial ATP, after reperfusion. OXF was found to be effective in preventing the haemodynamic and metabolic changes associated with myocardial stunning.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0019-5189
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1214-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9567753-Animals,
pubmed-meshheading:9567753-Cardiotonic Agents,
pubmed-meshheading:9567753-Dogs,
pubmed-meshheading:9567753-Heart,
pubmed-meshheading:9567753-Hemodynamics,
pubmed-meshheading:9567753-Myocardial Stunning,
pubmed-meshheading:9567753-Myocardium,
pubmed-meshheading:9567753-Oxyfedrine
|
pubmed:year |
1997
|
pubmed:articleTitle |
Oxyfedrine in myocardial stunning.
|
pubmed:affiliation |
Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|